Literature DB >> 1460420

A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica.

P R Cieslak1, H W Virgin, S L Stanley.   

Abstract

We used severe combined immunodeficient (SCID) mice to study resistance to invasive infection with Entamoeba histolytica. Seven of seven SCID mice developed liver abscesses when challenged intrahepatically with virulent HM1:IMSS strain E. histolytica trophozoites. Only one of seven similarly challenged immunocompetent congenic C.B-17 mice developed an abscess. Adoptive transfer of polyclonal rabbit anti-E. histolytica antiserum, but not preimmune rabbit serum, completely protected 7 of 12 SCID mice from intrahepatic challenge with ameba. These results demonstrate that lymphocyte-based immunity is important in protection against amebic liver abscess, and that anti-E. histolytica antibody can protect against amebic infection in this system. The SCID mouse may provide a powerful model for studying the components of protective immunity to invasive amebiasis.

Entities:  

Mesh:

Year:  1992        PMID: 1460420      PMCID: PMC2119462          DOI: 10.1084/jem.176.6.1605

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Proceedings: Attempts to infect inbred strains of rats and mice with Entamoeba histolytica.

Authors:  R A Neal; W G Harris
Journal:  Trans R Soc Trop Med Hyg       Date:  1975       Impact factor: 2.184

2.  Immunity to amebic infection in dogs.

Authors:  J C SWARTZWELDER; W H AVANT
Journal:  Am J Trop Med Hyg       Date:  1952-07       Impact factor: 2.345

3.  Pathology of human amebiasis.

Authors:  H Brandt; R P Tamayo
Journal:  Hum Pathol       Date:  1970-09       Impact factor: 3.466

4.  Antibody-dependent cell-mediated damage to schistosomula in vitro.

Authors:  A E Butterworth; R F Sturrock; V Houba; P H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

5.  A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.

Authors:  U E Schaible; R Wallich; M D Kramer; C Museteanu; M M Simon
Journal:  Behring Inst Mitt       Date:  1991-02

6.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

Authors:  G J Bancroft; K C Sheehan; R D Schreiber; E R Unanue
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

7.  Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).

Authors:  H Minagawa; S Sakuma; S Mohri; R Mori; T Watanabe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.

Authors:  B J Holaday; M D Sadick; Z E Wang; S L Reiner; F P Heinzel; T G Parslow; R M Locksley
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  The immunodeficient scid mouse as a model for human lymphatic filariasis.

Authors:  F K Nelson; D L Greiner; L D Shultz; T V Rajan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes.

Authors:  R J Lauzon; K A Siminovitch; G M Fulop; R A Phillips; J C Roder
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  24 in total

1.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

2.  Passive immunization during experimental amebic liver-abscess development.

Authors:  R Campos-Rodríguez; M Shibayama-Salas; J Pacheco-Yépez; A Martínez-Palomo; V Tsutsumi
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

3.  Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.

Authors:  B J Mann; C Y Chung; J M Dodson; L S Ashley; L L Braga; T L Snodgrass
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 4.  SCID mice and the study of parasitic disease.

Authors:  K B Seydel; S L Stanley
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis.

Authors:  K B Seydel; S L Stanley
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica.

Authors:  T Zhang; S L Stanley
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 7.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

8.  Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice.

Authors:  S L Stanley; T Zhang; D Rubin; E Li
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Use of bacterially expressed dsRNA to downregulate Entamoeba histolytica gene expression.

Authors:  Carlos F Solis; Julien Santi-Rocca; Doranda Perdomo; Christian Weber; Nancy Guillén
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

10.  Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence.

Authors:  Paul H Davis; Minghe Chen; Xiaochun Zhang; C Graham Clark; R Reid Townsend; Samuel L Stanley
Journal:  PLoS Negl Trop Dis       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.